The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors

The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands ( www.guidetopharmacology.org ), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13353/full . G protein‐coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ligand‐gated ion channels, voltage‐gated ion channels, other ion channels, nuclear hormone receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets. It is a condensed version of material contemporary to late 2015, which is presented in greater detail and constantly updated on the website www.guidetopharmacology.org , superseding data presented in the previous Guides to Receptors & Channels and the Concise Guide to PHARMACOLOGY 2013/14. It is produced in conjunction with NC‐IUPHAR and provides the official IUPHAR classification and nomenclature for human drug targets, where appropriate. It consolidates information previously curated and displayed separately in IUPHAR‐DB and GRAC and provides a permanent, citable, point‐in‐time record that will survive database updates.

[1]  I. Plaza-Menacho,et al.  RET in breast cancer: functional and therapeutic implications. , 2011, Trends in molecular medicine.

[2]  D. Tulasne,et al.  Met degradation: more than one stone to shoot a receptor down , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Samuel Bouyain,et al.  Receptor‐type tyrosine phosphatase ligands: looking for the needle in the haystack , 2013, The FEBS journal.

[4]  S. Peters,et al.  MET: a promising anticancer therapeutic target , 2012, Nature Reviews Clinical Oncology.

[5]  M. Mohammadi,et al.  Exploring mechanisms of FGF signalling through the lens of structural biology , 2013, Nature Reviews Molecular Cell Biology.

[6]  Johan Lennartsson,et al.  Stem cell factor receptor/c-Kit: from basic science to clinical implications. , 2012, Physiological reviews.

[7]  R. Roskoski,et al.  Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition. , 2013, Pharmacological research.

[8]  Guang Liang,et al.  Anticancer molecules targeting fibroblast growth factor receptors. , 2012, Trends in pharmacological sciences.

[9]  Matthew B. Dalva,et al.  EphBs: an integral link between synaptic function and synaptopathies , 2012, Trends in Neurosciences.

[10]  Zhon-Yin Zhang,et al.  Small molecule tools for functional interrogation of protein tyrosine phosphatases , 2013, The FEBS journal.

[11]  S. Hardy,et al.  Inside the human cancer tyrosine phosphatome , 2010, Nature Reviews Cancer.

[12]  B. Leitinger,et al.  Transmembrane collagen receptors. , 2011, Annual review of cell and developmental biology.

[13]  Carlos L. Arteaga,et al.  Treatment of HER2-positive breast cancer: current status and future perspectives , 2012, Nature Reviews Clinical Oncology.

[14]  Stanley J. Watson,et al.  The Fibroblast Growth Factor Family: Neuromodulation of Affective Behavior , 2012, Neuron.

[15]  Lydia Tabernero,et al.  Protein tyrosine phosphatase structure–function relationships in regulation and pathogenesis , 2013, The FEBS journal.

[16]  Hirofumi Inoue,et al.  Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands. , 2011, Journal of biochemistry.

[17]  N. Ip,et al.  Eph receptors at synapses: implications in neurodegenerative diseases. , 2012, Cellular signalling.

[18]  Paul H. Huang,et al.  Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling* , 2013, The Journal of Biological Chemistry.

[19]  Gou Young Koh,et al.  Orchestral actions of angiopoietin-1 in vascular regeneration. , 2013, Trends in molecular medicine.

[20]  Mary M. Bendig,et al.  HUMANIZED IMMUNOGLOBULIN REACTING WITH α4β7 INTEGRIN , 2010 .

[21]  G. Powers,et al.  Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2 , 1997 .

[22]  H. Baldwin,et al.  Role of Tie1 in shear stress and atherosclerosis. , 2011, Trends in cardiovascular medicine.

[23]  A. Larsen,et al.  Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. , 2011, Pharmacology & therapeutics.

[24]  G. Paratcha,et al.  New insights into the control of neurotrophic growth factor receptor signaling: Implications for nervous system development and repair , 2012, Journal of neurochemistry.

[25]  M. Shibuya,et al.  Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.

[26]  Omer Dushek,et al.  Non‐catalytic tyrosine‐phosphorylated receptors , 2012, Immunological reviews.

[27]  Y. Yamanashi,et al.  Activation of receptor protein-tyrosine kinases from the cytoplasmic compartment. , 2012, Journal of biochemistry.

[28]  R. Doebele,et al.  Treating ALK-positive lung cancer—early successes and future challenges , 2012, Nature Reviews Clinical Oncology.

[29]  L. Elferink,et al.  Checks and balances: interplay of RTKs and PTPs in cancer progression. , 2011, Biochemical pharmacology.

[30]  W. Birchmeier,et al.  Targeting MET in cancer: rationale and progress , 2012, Nature Reviews Cancer.

[31]  Pradeep J. Nathan,et al.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.

[32]  François Guillemot,et al.  From Cradle to Grave: The Multiple Roles of Fibroblast Growth Factors in Neural Development , 2011, Neuron.

[33]  Carlos F. Ibáñez,et al.  p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity , 2012, Trends in Neurosciences.

[34]  A. Herington,et al.  Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer. , 2013, Biochimica et biophysica acta.